Palatin Presents Data On Selective Melanocortin 4 Receptor Agonists
23 Oct 2024 //
PR NEWSWIRE
BerGenBio Selects 2nd Dose For Phase 2a STK11m NSCLC Trial
29 Jul 2024 //
PR NEWSWIRE
Artelo`s ART26.12 IND Application Cleared By FDA
15 Jul 2024 //
GLOBENEWSWIRE
Aprea Therapeutics Hosts Virtual KOL Event on APR-1051 on June 24
21 Jun 2024 //
GLOBENEWSWIRE
SeaStar Medical’s Cytopheretic Device Featured in Two PPT at the 42nd Vicenza
11 Jun 2024 //
GLOBENEWSWIRE
Nature Paper Details SeaStar`s Inflammation Control Mechanism
07 Jun 2024 //
GLOBENEWSWIRE
Nurix Announces NX-5948 BTK Degrader Data At EHA 2024
14 May 2024 //
GLOBENEWSWIRE
Foghorn Introduces FHD-909 and EP300 Degrader Oncology Programs at AACR 2024
09 Apr 2024 //
GLOBENEWSWIRE